Prospective study about immunization of attenuated live vaccines in children receiving immunosuppressants
Not Applicable
- Conditions
- Patients under treatment of immunosuppressants (CsA, FK, MZR, NNF, AZP)
- Registration Number
- JPRN-UMIN000007710
- Lead Sponsor
- Department of Nephrology and Rheumatology National Center for Child Health and Development
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Steroid use of more than 1mg/kg/d. 2. For renal transplant recipients, <1 year since transplantation or acute rejection within the previous 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Analysis of antibody acquisition after vaccination classified by each virus. 2) Analysis of maintenance of acquired immunity classified by each virus especially after 1 year. 3) Analysis of incididence of adverse events classified by each virus.
- Secondary Outcome Measures
Name Time Method 1) Analysis of causes of vaccine failure. 2) Analysis of causes of adverse events. 3) Analysis of effect for prevention of virus infection.